Stocks News

LAST PRICE
83.6900
TODAY'S CHANGE (%)
Trending Down-0.9600 (-1.1341%)

Bid / Lots
83.6300/ 7
Ask / Lots
84.7100/ 7
Open / Previous Close
84.3200 / 84.6500
Day Range
Low 83.5500
High 84.3200
52 Week Range
Low 56.6100
High 86.3600
Volume
5,442
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 21, 2024
- Prestige Consumer Healthcare Insider Sold Shares Worth $898,241, According to a Recent SEC Filing, from 4:08PM ET on Thursday Nov 21, 2024 by MT Newswires
  4:08PM ET on Thursday Nov 21, 2024 by MT Newswires
  Companies Mentioned: PBH
  04:08 PM EST, 11/21/2024 (MT Newswires) -- Ronald M. Lombardi, Director, Chief Executive Officer, on November 19, 2024, sold 10,875 shares in Prestige Consumer Healthcare (PBH) for $898,241. Following the Form 4 filing with the SEC, Lombardi has con...
Nov 15, 2024
- Prestige Consumer Healthcare Insider Sold Shares Worth $2,024,499, According to a Recent SEC Filing, from 3:27AM ET on Friday Nov 15, 2024 by MT Newswires
  3:27AM ET on Friday Nov 15, 2024 by MT Newswires
  Companies Mentioned: PBH
  03:27 AM EST, 11/15/2024 (MT Newswires) -- Christine Sacco, Chief Financial Officer, on November 12, 2024, sold 24,686 shares in Prestige Consumer Healthcare (PBH) for $2,024,499. Following the Form 4 filing with the SEC, Sacco has control over a to...
Nov 11, 2024
- DJ Prestige Consumer Hlthcr Is Maintained at Buy by DA Davidson, from 11:48AM ET on Monday Nov 11, 2024 by Dow Jones
  11:48AM ET on Monday Nov 11, 2024 by Dow Jones
  Companies Mentioned: PBH
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/PBH/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 11, 2024 11:48 ET (16:48 GMT)
Nov 7, 2024
- Prestige Consumer Healthcare's Fiscal Q2 Earnings Rise, Revenue Falls; 2025 Outlook Reiterated, from 9:05AM ET on Thursday Nov 07, 2024 by MT Newswires
  9:05AM ET on Thursday Nov 07, 2024 by MT Newswires
  Companies Mentioned: PBH
  09:05 AM EST, 11/07/2024 (MT Newswires) -- Prestige Consumer Healthcare (PBH) reported fiscal Q2 earnings Thursday of $1.09 per diluted share, up from $1.07 a year earlier. Analysts polled by Capital IQ expected $1.08. Total revenue for the quarter ...
- -- Earnings Flash (PBH) PRESTIGE CONSUMER HEALTHCARE Reports Q2 EPS $1.09, vs. Street Est of $1.08, from 6:03AM ET on Thursday Nov 07, 2024 by MT Newswires
  6:03AM ET on Thursday Nov 07, 2024 by MT Newswires
  Companies Mentioned: PBH
  06:03 AM EST, 11/07/2024 (MT Newswires) -- ...

Today
- DJ PTC Therapeutics Is Maintained at Overweight by Wells Fargo, from 1 hour ago by Dow Jones
  1 hour ago by Dow Jones
  Companies Mentioned: PTCT
Yesterday
- PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 17 hours ago by PR Newswire
  17 hours ago by PR Newswire
  Companies Mentioned: PTCT
- PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 17 hours ago by Dow Jones
  17 hours ago by Dow Jones
  Companies Mentioned: PTCT
Nov 22, 2024
- DJ Amphastar Pharmaceuticals Initiated at Overweight by Wells Fargo, from 9:08AM ET on Friday Nov 22, 2024 by Dow Jones
  9:08AM ET on Friday Nov 22, 2024 by Dow Jones
  Companies Mentioned: AMPH
- Hutchmed to Receive Milestone Payment for Takeda's Fruzaqla Launch in Japan, from 4:01AM ET on Friday Nov 22, 2024 by MT Newswires
  4:01AM ET on Friday Nov 22, 2024 by MT Newswires
  Companies Mentioned: TAK, HCM
Nov 21, 2024
- HUTCHMED Announces Launch by Takeda of FRUZAQLA(R) (fruquintinib) in Japan, from 11:30PM ET on Thursday Nov 21, 2024 by GlobeNewswire
  11:30PM ET on Thursday Nov 21, 2024 by GlobeNewswire
  Companies Mentioned: TAK, HCM
- HUTCHMED Announces Launch by Takeda of FRUZAQLA(R) (fruquintinib) in Japan, from 11:30PM ET on Thursday Nov 21, 2024 by Dow Jones
  11:30PM ET on Thursday Nov 21, 2024 by Dow Jones
  Companies Mentioned: TAK, HCM
Nov 20, 2024
- Press Release: HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee, from 4:30AM ET on Wednesday Nov 20, 2024 by Dow Jones
  4:30AM ET on Wednesday Nov 20, 2024 by Dow Jones
  Companies Mentioned: HCM
- HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee, from 4:30AM ET on Wednesday Nov 20, 2024 by Dow Jones
  4:30AM ET on Wednesday Nov 20, 2024 by Dow Jones
  Companies Mentioned: HCM
Nov 19, 2024
- DJ PTC Therapeutics Is Maintained at Overweight by JP Morgan, from 11:05AM ET on Tuesday Nov 19, 2024 by Dow Jones
  11:05AM ET on Tuesday Nov 19, 2024 by Dow Jones
  Companies Mentioned: PTCT

Prestige Consumer Healthcare Inc
NYSE:PBHUnited States

Search Criteria

Nov 21, 2024

Prestige Consumer Healthcare Insider Sold Shares Worth $898,241, According to a Recent SEC Filing, from 4:08PM ET on Thursday Nov 21, 2024 by MT Newswires

Nov 15, 2024

Prestige Consumer Healthcare Insider Sold Shares Worth $2,024,499, According to a Recent SEC Filing, from 3:27AM ET on Friday Nov 15, 2024 by MT Newswires

Nov 11, 2024

DJ Prestige Consumer Hlthcr Is Maintained at Buy by DA Davidson, from 11:48AM ET on Monday Nov 11, 2024 by Dow Jones

Nov 7, 2024

Prestige Consumer Healthcare's Fiscal Q2 Earnings Rise, Revenue Falls; 2025 Outlook Reiterated, from 9:05AM ET on Thursday Nov 07, 2024 by MT Newswires

-- Earnings Flash (PBH) PRESTIGE CONSUMER HEALTHCARE Reports Q2 EPS $1.09, vs. Street Est of $1.08, from 6:03AM ET on Thursday Nov 07, 2024 by MT Newswires

Peers Headlines

Today

DJ PTC Therapeutics Is Maintained at Overweight by Wells Fargo, from 1 hour ago by Dow Jones

Yesterday

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 17 hours ago by PR Newswire

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 17 hours ago by Dow Jones

Nov 22, 2024

DJ Amphastar Pharmaceuticals Initiated at Overweight by Wells Fargo, from 9:08AM ET on Friday Nov 22, 2024 by Dow Jones

Hutchmed to Receive Milestone Payment for Takeda's Fruzaqla Launch in Japan, from 4:01AM ET on Friday Nov 22, 2024 by MT Newswires

Nov 21, 2024

HUTCHMED Announces Launch by Takeda of FRUZAQLA(R) (fruquintinib) in Japan, from 11:30PM ET on Thursday Nov 21, 2024 by GlobeNewswire

HUTCHMED Announces Launch by Takeda of FRUZAQLA(R) (fruquintinib) in Japan, from 11:30PM ET on Thursday Nov 21, 2024 by Dow Jones

Nov 20, 2024

Press Release: HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee, from 4:30AM ET on Wednesday Nov 20, 2024 by Dow Jones

HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee, from 4:30AM ET on Wednesday Nov 20, 2024 by Dow Jones

Nov 19, 2024

DJ PTC Therapeutics Is Maintained at Overweight by JP Morgan, from 11:05AM ET on Tuesday Nov 19, 2024 by Dow Jones